| PRD_001235 | Name: | cyclic-tris-valinylselenazole | Formula: | C24 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001237 | Name: | Boc-Ala-Ala-Ala-Al-CHO | Formula: | C14 H27 N3 O5 | Definition date: | 2014-06-18 | Last modified: | 2023-11-03 |
|
| PRD_001255 | Name: | Promothiocin A | Formula: | C36 H47 N11 O8 S2 | Definition date: | 2014-12-10 | Last modified: | 2023-11-03 |
|
| PRD_000553 | Name: | APSTATIN | Formula: | C23 H33 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000555 | Name: | AERUGINOSIN 298-A | Formula: | C30 H48 N6 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000561 | Name: | FR901277 | Formula: | C47 H63 N9 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002103 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C30 H51 N5 O8 S | Definition date: | 2015-07-01 | Last modified: | 2023-11-03 |
|
| PRD_002107 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C31 H47 N5 O8 S2 | Definition date: | 2015-07-01 | Last modified: | 2023-11-03 |
|
| PRD_002126 | Name: | N-[4-(benzoylamino)butanoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-allothreoninamide | Formula: | C38 H54 N7 O10 P | Definition date: | 2014-12-03 | Last modified: | 2023-11-03 |
|
| PRD_002173 | Name: | N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H67 N5 O7 | Definition date: | 2016-07-27 | Last modified: | 2023-11-03 |
|
| PRD_002214 | Formula: | C35 H48 N6 O8 | Definition date: | 2015-12-02 | Last modified: | 2023-11-03 |
|
| PRD_002250 | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | Formula: | C32 H40 N4 O5 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002252 | Name: | N,N-diethyl-N~2~-[(2E)-3-phenylprop-2-enoyl]-L-asparaginyl-4-fluoro-N-[(naphthalen-1-yl)methyl]-L-phenylalaninamide | Formula: | C37 H39 F N4 O4 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002253 | Name: | (2S)-N-{(2S)-3-methoxy-1-[(naphthalen-1-ylmethyl)amino]-1-oxopropan-2-yl}-4-oxo-2-[(3-phenylpropanoyl)amino]-4-(1H-pyrrol-1-yl)butanamide (non-preferred name) | Formula: | C32 H34 N4 O5 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
| PRD_002254 | Name: | (2~{S})-~{N}-[(2~{S})-3-methoxy-1-(naphthalen-1-ylmethylamino)-1-oxidanylidene-propan-2-yl]-4-oxidanylidene-2-(3-phenylpropanoylamino)-4-piperidin-1-yl-butanamide | Formula: | C33 H40 N4 O5 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
| PRD_002255 | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-N-[(naphthalen-1-yl)methyl]-L-alaninamide | Formula: | C31 H38 N4 O4 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002256 | Name: | N-tert-butoxy-N~2~-(5-methyl-1,2-oxazole-3-carbonyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | Formula: | C28 H35 N5 O7 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
| PRD_002285 | Name: | N~2~-[(2S)-2-{[3-(6-chloro-1,3-benzothiazol-2-yl)-N-propanoyl-L-alanyl]amino}-2-cyclopentylacetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-N~6~,N~6~-dimethyl-L-lysinamide | Formula: | C37 H49 Cl N6 O5 S | Definition date: | 2018-02-28 | Last modified: | 2023-11-03 |
|
| PRD_000672 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-CO-NH-CH2PH | Formula: | C35 H44 N6 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002289 | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | Formula: | C68 H85 N13 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_000673 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-COO-CH2PH | Formula: | C35 H43 N5 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000674 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-CO-N(CH2PH)2 | Formula: | C42 H50 N6 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002290 | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | Formula: | C69 H90 N13 O12 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_000727 | Name: | PYOVERDIN G173 Fe Complex | Formula: | C49 H66 Fe N13 O21 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002338 | Name: | N-(3-phenylpropanoyl)-3-(1,3-thiazol-4-yl)-L-alanyl-N-[(1S,2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-valinamide | Formula: | C33 H42 N8 O4 S2 | Definition date: | 2019-10-02 | Last modified: | 2023-11-03 |
|